Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

LKFT holding history

Lakefront Biotherapeutics NV in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LKFT overviewAll 13F holders of LKFTFull Q2 2026 holdings

Shares (Q2 2026)
78
Value
$2.34K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of LKFT by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202678$2.34K<0.1%−66−45.8%ReducedHolders
Q1 2026144$4.32K<0.1%−38−20.9%ReducedHolders
Q4 2025182$5.95K<0.1%+88+93.6%AddedHolders
Q3 202594$3.26K<0.1%00.0%UnchangedHolders
Q2 202594$2.63K<0.1%−56−37.3%ReducedHolders
Q1 2025150$3.77K<0.1%−159−51.5%ReducedHolders
Q4 2024309$8.50K<0.1%+10+3.3%AddedHolders
Q3 2024299$8.61K<0.1%−91−23.3%ReducedHolders
Q2 2024390$9.66K<0.1%+31+8.6%AddedHolders
Q1 2024359$11.6K<0.1%−462−56.3%ReducedHolders
Q4 2023821$33.4K<0.1%+502+157.4%AddedHolders
Q3 2023319$11.0K<0.1%−397−55.4%ReducedHolders
Q2 2023716$29.1K<0.1%−79−9.9%ReducedHolders
Q1 2023795$30.7K<0.1%+268+50.9%AddedHolders
Q4 2022527$23.4K<0.1%−969−64.8%ReducedHolders
Q3 20221,496$64.0K<0.1%−154−9.3%ReducedHolders
Q2 20221,650$92.0K<0.1%−946−36.4%ReducedHolders
Q1 20222,596$161.0K<0.1%+1,182+83.6%AddedHolders
Q4 20211,414$78.0K<0.1%+733+107.6%AddedHolders
Q3 2021681$36.0K<0.1%−664−49.4%ReducedHolders
Q2 20211,345$92.0K<0.1%−12,711−90.4%ReducedHolders
Q1 202114,056$1.08M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.